Literature DB >> 30104942

Long-Term Functional Outcomes of Distal Femoral Replacements Compared to Geographic Resections for Parosteal Osteosarcomas of the Distal Femur.

Benjamin K Wilke1, Anna R Cooper1, C Parker Gibbs1, Mark T Scarborough1, Andre R Spiguel1.   

Abstract

Background: Parosteal osteosarcoma is a rare tumor with increased survival compared to conventional high-grade osteosarcoma. Due to this increased survival comes the need for reconstructive options that provide good long-term functional results. Current treatment methods include geographic resection with allograft reconstruction versus resection and reconstruction with a distal femoral replacement. Purpose: Our purpose was to compare the long-term functional outcomes of distal femoral replacements to allograft reconstructions, using the musculoskeletal tumor society (MSTS) scoring system.
Methods: After querying our database, 12 patients were identified and completed a MSTS questionnaire.
Results: There was no difference in functional outcomes between the cohorts at an average of 14 years follow up for the endoprosthetic group and 25 years of follow up for the geographic resection group.
Conclusion: At long-term follow-up, patients who undergo a distal femoral replacement for a parosteal osteosarcoma have no difference in functional outcomes compared to those who undergo an allograft reconstruction.Level of Evidence: IV.

Entities:  

Mesh:

Year:  2018        PMID: 30104942      PMCID: PMC6047406     

Source DB:  PubMed          Journal:  Iowa Orthop J        ISSN: 1541-5457


  12 in total

1.  Clinical outcome of 38 patients with juxtacortical osteosarcoma.

Authors:  H T Temple; S P Scully; R J O'Keefe; S Katapurum; H J Mankin
Journal:  Clin Orthop Relat Res       Date:  2000-04       Impact factor: 4.176

2.  Treatment and outcome of parosteal osteosarcoma: biological versus endoprosthetic reconstruction.

Authors:  Philipp T Funovics; Frederik Bucher; Cyril D Toma; Rainer I Kotz; Martin Dominkus
Journal:  J Surg Oncol       Date:  2011-01-15       Impact factor: 3.454

3.  Parosteal osteosarcoma. Treatment by wide resection and prosthetic replacement.

Authors:  T G Kavanagh; S R Cannon; J Pringle; D J Stoker; H B Kemp
Journal:  J Bone Joint Surg Br       Date:  1990-11

4.  Parosteal osteosarcoma. 2-23-year follow-up of 33 patients.

Authors:  P Ritschl; C Wurnig; G Lechner; A Roessner
Journal:  Acta Orthop Scand       Date:  1991-06

5.  A system for the surgical staging of musculoskeletal sarcoma.

Authors:  W F Enneking; S S Spanier; M A Goodman
Journal:  Clin Orthop Relat Res       Date:  1980 Nov-Dec       Impact factor: 4.176

6.  Parosteal osteosarcoma.

Authors:  M Campanacci; P Picci; F Gherlinzoni; A Guerra; F Bertoni; J R Neff
Journal:  J Bone Joint Surg Br       Date:  1984-05

7.  The surgical treatment of parosteal osteosarcoma in long bones.

Authors:  W F Enneking; D Springfield; M Gross
Journal:  J Bone Joint Surg Am       Date:  1985-01       Impact factor: 5.284

8.  The prognostic and therapeutic factors which influence the oncological outcome of parosteal osteosarcoma.

Authors:  M Laitinen; M Parry; J I Albergo; L Jeys; A Abudu; S Carter; V Sumathi; R Grimer
Journal:  Bone Joint J       Date:  2015-12       Impact factor: 5.082

9.  Parosteal osteogenic sarcoma.

Authors:  K K Unni; D C Dahlin; J W Beabout; J C Ivins
Journal:  Cancer       Date:  1976-05       Impact factor: 6.860

10.  A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system.

Authors:  W F Enneking; W Dunham; M C Gebhardt; M Malawar; D J Pritchard
Journal:  Clin Orthop Relat Res       Date:  1993-01       Impact factor: 4.176

View more
  1 in total

1.  Oncological and Functional Outcomes after Hemicortical Resection and Biological Reconstruction Using Allograft for Parosteal Osteosarcoma of the Distal Femur.

Authors:  Olga D Savvidou; Stavros Goumenos; Ioannis Trikoupis; Angelos Kaspiris; Dimitra Melissaridou; Panagiotis Gavriil; Jimmy Georgoulis; Panayiotis J Papagelopoulos
Journal:  Sarcoma       Date:  2022-06-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.